Biogen looks to its bench to replace chairman Papadopoulos; Lilly, AbbVie gene therapy partner makes CSO hire
→ Caroline Dorsa will chair the board at Biogen after its annual meeting in June, the company revealed on Wednesday. Last month, Stelios Papadopoulos said he would retire from the post that he’s held since 2014. Dorsa, a board member at Biogen since 2010, concluded her 21-year career at Merck as SVP, global human health, strategy and integration from 2008-09. She also has board seats at Intellia and Illumina.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
